Medial Officer Class 3/Medical Officer Class 4

Date published: Jan 22, 2026, 11:45 AM

Location

Canberra ACT, Sydney NSW, Melbourne VIC, Brisbane QLD

Description

The Medical Officer Classification 3

Contributes expert clinical advice in undertaking complex evaluations to support the regulation of therapeutic goods, particularly prescription medicines.

Working under general direction, the MO3 contributes to scientific and clinical assessments, regulatory decision-making, policy development, and stakeholder engagement to ensure the safety, efficacy, and quality of therapeutic goods, particularly prescription medicines available in Australia.

  • Salary: ($170,816 to $178,846) plus 15.4% superannuation
  • Job reference: 25-MRDIV-30596
The Medical Officer Classification 4 in PMAB

Provides leadership and advanced clinical and regulatory expertise in the evaluation and regulation of therapeutic goods, with a primary focus on prescription medicines, to ensure they meet Australian standards for safety, efficacy, and quality.

Working under general direction, the officer leads and oversees scientific and clinical assessment of applications for new medicines, variations to existing products, and post-market reviews. This role involves applying clinical knowledge to regulatory decision-making, interpreting complex medical and scientific data, and leading the development of regulatory advice, documentation and policy contributions.

  • Salary ($186,279 to $205,038) plus 15.4% superannuation
  • Job reference: 25-MRDIV-30596

Both Positions: Ongoing & Non-ongoing

Non-ongoing employment may be offered for up to 12 - 24 months, with a possibility of extension

Full-time & Part-time 

Apply

Medical Officer Class 3 - Contact officer: Karen Detering Email: Karen.detering@health.gov.au Phone: 0419874796

Prescription Medicines Authorisation Branch Contact officer: Nitin Bagul Email: Nitin.bagul@health.gov.au Phone: 0481907598 Medicines Regulation Division Prescription Medicines Authorisation Branch 

Applications close

Feb 16, 2026, 00:00 AM
Close overlay